Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
about
Moxalactam pharmacokinetics in childrenA comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infectionComparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeaeCefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.Prediction of Clearance and Volume of Distribution in the Obese from Normal Weight Subjects : An Allometric Approach.Effects of general and local anesthesia on the pharmacokinetics of cefazolin in patients undergoing orthopedic surgery.Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjectsEffect of probenecid on the pharmacokinetics of moxalactam.Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia.Single- and multiple-dose pharmacokinetics of moxalactam in normal subjectsRandomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.Comparative pharmacokinetics of ceftazidime and moxalactam.Pharmacokinetics of moxalactam in elderly subjects.
P2860
Q34250667-14C75DFC-5727-4C0E-8486-5C13307195C2Q34707883-7912B5ED-B5D3-4DC8-8299-975137C6DF00Q35671926-D56FD6D4-65F5-4631-8948-F67847B91314Q35676060-9759E140-B2B9-454E-9D21-EEA3BED76516Q35715192-479DEEAA-0C5E-4414-AB00-BF5D5F73FD86Q35740078-1455BA34-2269-4FFD-8473-8B14BF425A45Q35740391-C49EDB0C-99EC-4A9F-87DB-A4E8EEF31231Q37856088-DE7EB5CE-9FAA-4517-86DF-8AB52905A857Q38016504-C2A24540-6E9E-4912-83A2-97BA8627D55DQ38930369-5E8130B9-643E-4691-814E-88B4666D0C42Q39849976-1602C371-3D48-4309-B29D-2EE0F5C3EFF8Q39855761-C75BDD3F-AE71-4E95-A808-FEB5E17FC36FQ39856317-F23EF668-3170-42D4-9CE7-3F979F3319CAQ40728370-0B384B8C-1DDB-4F92-A91A-8F2B023D1CFAQ41850216-A09AE768-5917-437C-90DF-7107BBA960D2Q42248639-96AC3CD2-BBDF-4FE5-8E04-ACA9F0862E9AQ42926813-BB316A1D-1930-43B9-817D-E3FC645D93ABQ42929645-A087F258-6941-45EA-B077-12EF4CB1062A
P2860
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
description
1981 nî lūn-bûn
@nan
1981 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@ast
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@en
type
label
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@ast
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@en
prefLabel
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@ast
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@en
P2093
P2860
P356
P1476
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
@en
P2093
D A Spyker
G R Donowitz
W K Bolton
W M Scheld
P2860
P304
P356
10.1128/AAC.19.4.613
P407
P577
1981-04-01T00:00:00Z